Katherine Fedora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Katherine Fedora has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Qorri’ Aina
Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia
2 shared publications - Farahdina Farahdina
Department of Child Health, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
1 shared publication - Feelin Fatwa Titiharja
Faculty of Medicine, Universitas Muhammadiyah Malang, Malang, East Java, Indonesia
1 shared publication - Laili Nur Rosyidah
Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia
1 shared publication Muhammad Faizi
Department of Child Health, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia
1 shared publication- Nur Lailatun Ni’mAh
Faculty of Medicine, Universitas Islam Malang, Malang, East Java, Indonesia
1 shared publication
Latest Publications
- Open Access
- 18 October 2024
- Published by Taylor & Francis in Annals of Medicine
- Vol. 56 (1) , 2400313
Vitamin D supplementation decrease asthma exacerbations in children: a systematic review and meta-analysis of randomized controlled trials
Observational studies have linked low vitamin D (VD) levels to increased asthma attacks in children. Subsequent meta-analyses of adults and children revealed that VD treatment might benefit asthmatic patients by reducing the incidence of exacerbations. Therefore, this review aims to analyze the effects of VD supplementation in reducing asthma exacerbations in children. Published reports from PubMed, Cochrane, and Google Scholar were systematically searched until April 2023. The study protocol was registered in the PROSPERO database CRD42023411796. Randomized controlled trial studies were included in this review. Meta-analysis was performed using Cochrane RevMan 5.1 and presented with 95% confidence intervals (CIs). Ten relevant studies enrolled 1243 asthmatic children (631 children receiving vitamin D3 supplementation, 612 children receiving placebo) were included in this review. Our pooled analysis found that VD supplementation had a significant effect on lowering the total number of asthma exacerbations (RR 0.62; 95% CI: 0.44, 0.87; p = 0.01). Subgroup analysis revealed that a daily dose of VD given based on standard daily dose recommendation had a significant improvement on asthma exacerbations [(RR 0.41; 95% CI: 0,18, 0,92; p = 0.03). Vitamin D supplementation can lower the occurrence of exacerbations in children with asthma, along with the improvement of FEV1.
- 18 October 2024
- Published by Taylor & Francis in Annals of Medicine
- Vol. 56 (1) , 2400313
Open AccessVitamin D supplementation decrease asthma exacerbations in children: a systematic review and meta-analysis of randomized controlled trials
Observational studies have linked low vitamin D (VD) levels to increased asthma attacks in children. Subsequent meta-analyses of adults and children revealed that VD treatment might benefit asthmatic patients by reducing the incidence of exacerbations. Therefore, this review aims to analyze the effects of VD supplementation in reducing asthma exacerbations in children. Published reports from PubMed, Cochrane, and Google Scholar were systematically searched until April 2023. The study protocol was registered in the PROSPERO database CRD42023411796. Randomized controlled trial studies were included in this review. Meta-analysis was performed using Cochrane RevMan 5.1 and presented with 95% confidence intervals (CIs). Ten relevant studies enrolled 1243 asthmatic children (631 children receiving vitamin D3 supplementation, 612 children receiving placebo) were included in this review. Our pooled analysis found that VD supplementation had a significant effect on lowering the total number of asthma exacerbations (RR 0.62; 95% CI: 0.44, 0.87; p = 0.01). Subgroup analysis revealed that a daily dose of VD given based on standard daily dose recommendation had a significant improvement on asthma exacerbations [(RR 0.41; 95% CI: 0,18, 0,92; p = 0.03). Vitamin D supplementation can lower the occurrence of exacerbations in children with asthma, along with the improvement of FEV1.
- Open Access
- 25 March 2024
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 06 (01) , 49-59
Metabolomics as a Candidate for Endometriosis Biomarker: A Systematic Review
Background: To date, diagnosis is still a challenge in managing endometriosis. There is a need to develop a less invasive yet accurate approach, such as a biomarker, to help diagnose endometriosis earlier and more precisely. Metabolomics, the study of metabolites, are thought to provide a more accurate relation to phenotype compared to other omics technology and may help develop endometriosis biomarkers. This review aims to systematically summarize evidence regarding the use of metabolomics studies in the diagnosis of endometriosis. Methods: This review was conducted according to PRISMA 2020 guidelines. Including studies on endometriosis and metabolomics in Medline, Embase, and Cochrane Library to May 2022. Inclusion: Women of reproductive age, laparoscopically diagnosed — exclusion criteria: no full-text, languages other than English, and animal studies. Papers were screened and extracted using Covidence, appraised using Newcastle-Ottawa Scale (NOS), by two independent reviewers. Results: A total of 33 studies are included in this review, and 24 showed positive results regarding the metabolites identified and their association with endometriosis. Twenty-four studies reported good area under curve (AUC), sensitivity, and specificity scores in diagnosing endometriosis using a prediction model from the attained metabolites. However, the summary of these scores is not feasible due to the lack of standardization in reporting metabolomics studies. Both serum and endometriotic lesion microenvironments, such as peritoneal fluid, endometrioma, follicular fluid, and tissue lesions, give essential information on which metabolites are altered in endometriosis. Phosphatidylcholine (PC), acylcarnitines (AC), and sphingomyelins (SM) are these studies’ most frequent significant metabolites, but their levels vary. Although all studies had an overall good appraisal score, regarding confounders included, the variation in their methods of analysis and prediction model approach should be interpreted with caution. These predictions are also mostly done without using two different data groups for test and validation. Conclusions: Metabolomics studies may become an alternative for a less invasive approach to diagnosing endometriosis. This review revealed how encouraging results from metabolomics studies are. However, the need for more standardization in the study report and preliminary design for making a prediction model is still in the way of fully trusting metabolomics studies to account for endometriosis diagnostic biomarkers. Registration: PROSPERO CRD42022334916
- 25 March 2024
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 06 (01) , 49-59
Open AccessMetabolomics as a Candidate for Endometriosis Biomarker: A Systematic Review
Background: To date, diagnosis is still a challenge in managing endometriosis. There is a need to develop a less invasive yet accurate approach, such as a biomarker, to help diagnose endometriosis earlier and more precisely. Metabolomics, the study of metabolites, are thought to provide a more accurate relation to phenotype compared to other omics technology and may help develop endometriosis biomarkers. This review aims to systematically summarize evidence regarding the use of metabolomics studies in the diagnosis of endometriosis. Methods: This review was conducted according to PRISMA 2020 guidelines. Including studies on endometriosis and metabolomics in Medline, Embase, and Cochrane Library to May 2022. Inclusion: Women of reproductive age, laparoscopically diagnosed — exclusion criteria: no full-text, languages other than English, and animal studies. Papers were screened and extracted using Covidence, appraised using Newcastle-Ottawa Scale (NOS), by two independent reviewers. Results: A total of 33 studies are included in this review, and 24 showed positive results regarding the metabolites identified and their association with endometriosis. Twenty-four studies reported good area under curve (AUC), sensitivity, and specificity scores in diagnosing endometriosis using a prediction model from the attained metabolites. However, the summary of these scores is not feasible due to the lack of standardization in reporting metabolomics studies. Both serum and endometriotic lesion microenvironments, such as peritoneal fluid, endometrioma, follicular fluid, and tissue lesions, give essential information on which metabolites are altered in endometriosis. Phosphatidylcholine (PC), acylcarnitines (AC), and sphingomyelins (SM) are these studies’ most frequent significant metabolites, but their levels vary. Although all studies had an overall good appraisal score, regarding confounders included, the variation in their methods of analysis and prediction model approach should be interpreted with caution. These predictions are also mostly done without using two different data groups for test and validation. Conclusions: Metabolomics studies may become an alternative for a less invasive approach to diagnosing endometriosis. This review revealed how encouraging results from metabolomics studies are. However, the need for more standardization in the study report and preliminary design for making a prediction model is still in the way of fully trusting metabolomics studies to account for endometriosis diagnostic biomarkers. Registration: PROSPERO CRD42022334916
- Open Access
- 1 January 2023
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 11 (F) , 38-43
The Role of Telemedicine in Type 1 Diabetes Children during COVID-19 Pandemic Era: A Systematic Review and Meta-analysis
BACKGROUND: The COVID-19 pandemic determined a profound impact on the routine follow-up of type 1 diabetes (T1D) children. Telemedicine represents a critical tool to guarantee regular care for these patients in this form. AIM: The purpose of this study was to assess the impact of telemedicine programs during the COVID-19 pandemic era on T1D children. PATIENTS AND METHODS: Studies from PubMed, Cochrane, and Directory of Open Access Journals from December 2021, to February 18, 2022, were conducted to calculate the pooled mean difference using either a random or fixed-effect model in Review Manager version 5.3. Our study has applied to ensure that our procedures, including record collection, extraction of data, quality evaluation, and statistical analysis, adhere to the Preferred Reporting Items for Systematic Examination and Meta-Analysis guidelines. RESULTS: Three articles relevant to the current study (436 children). Our pooled analysis found that there was an impact of telemedicine in reducing the HbA1c (mean diff: 5.64 [95% confidence interval (CI) 3.71–7.57], p < 0.00001). However, the physical activity was not affected by the telemedicine program (mean diff: −37.25 [95% CI −317.53–243.02], p = 0.79). CONCLUSION: Our findings suggest that telemedicine has a role in T1D children controlling HbA1c during the COVID-19 pandemic. Meanwhile, telehealth has emerged as a promising alternate mode of health-care delivery. Its utility during the pandemic warrants further investigation.
- 1 January 2023
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 11 (F) , 38-43
Open AccessThe Role of Telemedicine in Type 1 Diabetes Children during COVID-19 Pandemic Era: A Systematic Review and Meta-analysis
BACKGROUND: The COVID-19 pandemic determined a profound impact on the routine follow-up of type 1 diabetes (T1D) children. Telemedicine represents a critical tool to guarantee regular care for these patients in this form. AIM: The purpose of this study was to assess the impact of telemedicine programs during the COVID-19 pandemic era on T1D children. PATIENTS AND METHODS: Studies from PubMed, Cochrane, and Directory of Open Access Journals from December 2021, to February 18, 2022, were conducted to calculate the pooled mean difference using either a random or fixed-effect model in Review Manager version 5.3. Our study has applied to ensure that our procedures, including record collection, extraction of data, quality evaluation, and statistical analysis, adhere to the Preferred Reporting Items for Systematic Examination and Meta-Analysis guidelines. RESULTS: Three articles relevant to the current study (436 children). Our pooled analysis found that there was an impact of telemedicine in reducing the HbA1c (mean diff: 5.64 [95% confidence interval (CI) 3.71–7.57], p < 0.00001). However, the physical activity was not affected by the telemedicine program (mean diff: −37.25 [95% CI −317.53–243.02], p = 0.79). CONCLUSION: Our findings suggest that telemedicine has a role in T1D children controlling HbA1c during the COVID-19 pandemic. Meanwhile, telehealth has emerged as a promising alternate mode of health-care delivery. Its utility during the pandemic warrants further investigation.